Skip to content
bioprocess.updates
AdvertisementHouse ad · Perfusion seriesPerfusion, explained: a three-part seriesRead the seriesBioprocessUpdates

Bioprocess scale-up, AI and cell & gene therapy, from primary sources.

Every piece links its primary source at the top and answers one question: what changes for a plant.

Updated 68 pieces 9 deep reads 321 primary sources read for them

Deep Reads

In-depth reports, each built from dozens of primary sources

One question per report: what the papers, regulators and company data say, what holds up, and what a plant should do about it.

All deep reads

News

Daily briefs from company releases, papers and regulators

Advertisement
House adYour equipment, in front of the people who scale bioprocesses.

Display, sponsored research and LinkedIn carousels, always marked as sponsored. Same source rules as everything else.

Advertise with us
BioprocessUpdates

Companies in our coverage

Editorial coverage from primary sources. No company on this list paid to appear. See Interests.

Scale-Up & Capacity

Scale-up is taking a bioprocess from the lab or pilot bioreactor to commercial production without losing titer or quality. This section covers upstream and downstream scale-up...

AI & Digital Bioprocessing

AI and digital bioprocessing means using data, models and automation to run a bioprocess: machine learning, process analytical technology (PAT) such as Raman and capacitance probes,...

Cell & Gene Therapy

Cell and gene therapy manufacturing covers how viral vectors (AAV, lentivirus), CAR-T and other cell therapies are produced, purified and scaled under GMP. This section follows...